Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +649.0% | +174.8% | 2 / 3 | +31.8% | +2.30 pp | +1.46 pp | +13.2% | 0.61 | 10.20 | 1.393 | +31,8% | 24,7 | +649,0% | 10.20 | 30.33 | −66,4% |
| Pts | 12 | 12 | 8 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 14.900 (close price on 2026-10-19)EPS (TTM): 1.461
Financial charts
1.Revenue & growth
VND bn1.372Q2/26
1.Revenue & growth
VND bn1.372Q2/26
2.Profit & growth
VND bn51,2Q2/26
3.Profit mix (Penman)
VND bn70,6Q2/26
4.Margins & cost structure
%2.5%Q2/26
5.Returns & cash cycle
% · days18.5%Q2/26
6.Earnings quality & cash
VND bn76,7Q2/26
7.Asset structure
VND bn439Q2/26
8.Funding & debt health
VND bn · times439Q2/26
9.Revenue backlog
VND bn7,46Q2/26
10.Valuation
times · %5,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.606Q2/26
Adjusted EPS growth, latest quarter
15,5× higher
Average adjusted EPS growth, 3 quarters
442%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26